These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21081199)

  • 1. Pharmacology of 5-HT6 receptors--Part 1. Preface.
    Borsini F
    Int Rev Neurobiol; 2010; 94():xi-xii. PubMed ID: 21081199
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of 5-HT6 receptor ligands.
    Mancinelli A
    Int Rev Neurobiol; 2010; 94():153-72. PubMed ID: 21081206
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophysiology of 5-HT6 receptors.
    Tassone A; Madeo G; Sciamanna G; Pisani A; Bonsi P
    Int Rev Neurobiol; 2010; 94():111-28. PubMed ID: 21081204
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-HT6 medicinal chemistry.
    Liu KG; Robichaud AJ
    Int Rev Neurobiol; 2010; 94():1-34. PubMed ID: 21081200
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement.
    Di Chiara G; Valentini V; Fenu S
    Int Rev Neurobiol; 2011; 96():111-39. PubMed ID: 21329786
    [No Abstract]   [Full Text] [Related]  

  • 6. Patents.
    Ruiz NV; Oranias Olsina G
    Int Rev Neurobiol; 2010; 94():35-66. PubMed ID: 21081201
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-HT6 receptor ligands as antidementia drugs.
    Mitchell ES
    Int Rev Neurobiol; 2011; 96():163-87. PubMed ID: 21329788
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-HT6 receptor characterization.
    Riccioni T
    Int Rev Neurobiol; 2010; 94():67-88. PubMed ID: 21081202
    [No Abstract]   [Full Text] [Related]  

  • 9. Other 5-HT6 receptor-mediated effects.
    Borsini F
    Int Rev Neurobiol; 2011; 96():189-91. PubMed ID: 21329789
    [No Abstract]   [Full Text] [Related]  

  • 10. The central role of 5-HT6 receptors in modulating brain neurochemistry.
    Dawson LA
    Int Rev Neurobiol; 2011; 96():1-26. PubMed ID: 21329782
    [No Abstract]   [Full Text] [Related]  

  • 11. Graham Johnston: bringing success to neuroscience through medicinal chemistry. Preface.
    Beart PM; Balcar VJ
    Neurochem Res; 2009 Oct; 34(10):1696-7. PubMed ID: 19484383
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-HT6 pharmacology inconsistencies.
    Borsini F; Bordi F; Riccioni T
    Pharmacol Biochem Behav; 2011 Apr; 98(2):169-72. PubMed ID: 21192969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT6 receptor signal transduction second messenger systems.
    Codony X; Burgueño J; Ramírez MJ; Vela JM
    Int Rev Neurobiol; 2010; 94():89-110. PubMed ID: 21081203
    [No Abstract]   [Full Text] [Related]  

  • 14. Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges.
    Brioschi AM; Calderoni S; Zara GP; Priano L; Gasco MR; Mauro A
    Prog Brain Res; 2009; 180():193-223. PubMed ID: 20302836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitters of the brain: serotonin, noradrenaline (norepinephrine), and dopamine.
    Blows WT
    J Neurosci Nurs; 2000 Aug; 32(4):234-8. PubMed ID: 10994538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
    Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug addiction and brain targets: from preclinical research to pharmacotherapy.
    Rahman S
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):391-2. PubMed ID: 19128198
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 19. Studying monoamine transporters: beyond hypermonoaminaemia.
    Reith ME
    J Neurosci Methods; 2005 Apr; 143(1):1-2. PubMed ID: 15763131
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of serotonergic agents in the clinical assessment of central serotonin function.
    Murphy DL; Mueller EA; Garrick NA; Aulakh CS
    J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.